{
    "title": "434 MHz Cancer Therapy",
    "inventor_name": "Dr. John Holt",
    "publication_year": 2003,
    "device_name": "434 MHz Ultra-High-Frequency Radiowave Therapy System",
    "goal": "Selective destruction of cancer cells by disrupting their glucose metabolism using ultra-high-frequency electromagnetic radiation combined with glucose-blocking agents.",
    "problem_addressed": "Cancer (malignant tumor growth).",
    "concept_summary": "The method injects an intravenous solution of oxidised amino-acid compounds (e.g., cystine, oxidised glutathione) that mimic glucose and deliver oxygen to cancer cells. Immediately thereafter, the patient is exposed to 434 MHz electromagnetic radiation for 20-25 minutes. The radiation temporarily forces cancer cells to burn glucose without oxygen, causing metabolic stress and cell death while normal cells are only briefly stimulated to divide for repair.",
    "detailed_description": null,
    "category": "Electromagnetism & Magnetism",
    "principles": [
        "Selective metabolic disruption of cancer cells",
        "Resonance-induced cellular vibration",
        "Microwave-frequency electromagnetic activation of glucose oxidation",
        "Use of oxidised amino-acid analogs as glucose-blocking agents"
    ],
    "scientific_domains": [
        "Medical Physics",
        "Oncology",
        "Radiology",
        "Biochemistry"
    ],
    "mechanisms_of_action": [
        "434 MHz radiation temporarily activates glucose burning in cancer cells without oxygen",
        "Oxidised cystine/glutathione act as glucose analogs, delivering oxygen and causing metabolic overload",
        "Resonance vibration of cancer cells (\"shaking like a bell\") enhances uptake of the blocking agent"
    ],
    "materials": [
        "cystine",
        "oxidised glutathione",
        "penicillamine disulfide",
        "cysteine sulfoxide",
        "sulfoximine",
        "sulfonic compounds"
    ],
    "energy_sources": [
        "434 MHz electromagnetic radiation (microwave/UHF)"
    ],
    "inputs": [
        "Intravenous glucose-blocking agent solution (~50 ml)",
        "434 MHz UHF radiation exposure (20-25 min)"
    ],
    "outputs": [
        "Cancer cell death",
        "Reduction of tumor mass (10-20 % per treatment course)",
        "Potential cure in selected cases"
    ],
    "claimed_performance": "In a series of 15 treatments over three weeks, patients showed 10-20 % reduction in tumor mass; a mesothelioma patient remained disease-free after seven treatment courses.",
    "experimental_evidence": "Results reported from 15 treatments over three weeks; anecdotal case of a mesothelioma patient alive after seven courses. No peer-reviewed clinical trial data provided.",
    "replication_status": "No independent replication or peer-reviewed study mentioned.",
    "keywords": [
        "434 MHz",
        "UHF radiation",
        "cancer therapy",
        "glucose blocking",
        "cystine",
        "oxidised glutathione",
        "microwave oncology"
    ],
    "related_technologies": [
        "Rife frequency therapy",
        "Hyperthermia treatment",
        "Microwave ablation"
    ],
    "controversy_level": "high",
    "confidence_score": 0.7,
    "practicability_score": 0.5,
    "fringe_score": 0.8,
    "evidence_strength": 0.4,
    "risk_score": 0.3,
    "trl_estimate": 4,
    "source_urls": [
        "http://www.drholtsupport.com",
        "http://www.the-institute.com.au",
        "http://www.rife.de/holts_documentation.html",
        "http://www.drholtsupport.com/simple.asp"
    ],
    "organizations": [
        "Holt Clinic",
        "Western Australia Health Services (implicit)"
    ],
    "applications": [
        "Cancer treatment",
        "Potential adjunct for viral or autoimmune conditions (as per patent abstracts)"
    ],
    "limitations": [
        "Requires intravenous access and a PICC line for some patients",
        "Contraindicated in thalassaemia, recent chemotherapy, fluid collections (ascites, pleural effusion), and smokers",
        "Side-effects include mild warming and occasional transient brain-glucose deprivation",
        "Efficacy data limited to small, non-controlled case series"
    ],
    "open_questions": [
        "What is the comparative efficacy versus standard chemotherapy/radiotherapy?",
        "Can the treatment be reliably reproduced in independent clinical settings?",
        "What are the optimal dosing parameters for the blocking agents and radiation exposure?",
        "Long-term safety of repeated UHF exposure"
    ],
    "red_flags": [
        "Lack of peer-reviewed clinical trial data",
        "Reliance on anecdotal case reports",
        "Potential for unproven claims of cure",
        "Use of non-standard medical terminology (e.g., \"UHF creates resonance like a bell\")"
    ],
    "evidence_quotes": [
        "I discovered in 1973 that this frequency ... will temporarily activate cancer's burning of glucose without oxygen for between 20 and 30 minutes.",
        "Results have come from 15 treatments over three weeks ... The infusion of the glucose blocking agent takes approximately fifteen minutes and is immediately followed by 20 to 25 minutes of UHF therapy.",
        "The maximum number of treatment courses given was seven in a patient with mesothelioma treated twelve years ago who now is alive and well without evidence of the disease."
    ]
}